References
- McDowall RD . Developing a strategy for a regulated electronic bioanalytical laboratory. Bioanalysis6 (2), 165–184 (2014).
- Nussbeck SY , WeilP, MenzelJ, MarzecB, LorbergK, SchwappachB. The laboratory notebook in the 21st century. EMBO Rep. 15 (6), 631–634 (2014).
- Song Y , DhoddaR, ZhangJ, SydorJ. A high efficiency, high quality and low cost internal regulated bioanalytical laboratory to support drug development needs. Bioanalysis6 (10), 1295–1309 (2014).
- Shoup RE , BeatoBD, PisekAet al. Implementation of an electronic laboratory notebook to accelerate data review in bioanalysis. Bioanalysis5 (13), 1677–1689 (2013).
- Zeng J , HillmanM, ArnoldM. Impact of the implementation of a well-designed electronic laboratory notebook on bioanalytical laboratory function. Bioanalysis3 (13), 1501–1511 (2011).
- GAMP® 5: A Risk-Based Approach to Compliant GxP Computerized System . International Society for Pharmaceutical Engineering, Bethesda, MD, USA (2008).
- OECD series on Principles of Good Laboratory Practice and Compliance Monitoring Number 17: application of GLP principles to computerized systems . Organization for Economic Co-operation and Development, Paris, France (2016).
- Guidance for Industry Part 11, Electronic Records; Electronic Signatures — Scope and Application . US FDA, MD, USA (2003).
- Reflection Paper on Expectations for Electronic Source Data and Data Transcribed to Electronic Data Collection Tools in Clinical Trials . European Medicines Agency, London, UK (2010).